Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include CRISPR and Genetic Engineering, Cancer-related molecular mechanisms research, MicroRNA in disease regulation, and Circular RNAs in diseases.
SELECT: high-precision genome editing strategy via integration of CRISPR–Cas and DNA damage response for cross-species applications
An Insect-Proof Net Technique Can Help Reduce Pesticide Application on Vegetables
Metabolic reprogramming signature predicts prognosis and immune landscape in small cell lung cancer: MOCS2 validation and implications for personalized therapy
Development and validation of a 55-Plex X-STR NGS panel for forensic casework: Population genetics, mutation analysis, and kinship discrimination
Immunoregulatory role of the gut microbiota in inflammatory depression
Development of KASP markers assisted with soybean drought tolerance in the germination stage based on GWAS
Comparative Insecticidal Activity and Mechanism of Isocycloseram versus Other GABAergic Insecticides against the Fall Armyworm
Association between baseline C‑reactive protein level and survival outcomes for cancer patients treated with immunotherapy: A meta‑analysis
Differences of circular RNA expression profiles between monozygotic twins' blood, with the forensic application in bloodstain and saliva
Circular RNA as a Potential Biomarker for Forensic Age Prediction
Forensic age estimation from human blood using age-related microRNAs and circular RNAs markers
The estimation of bloodstain age utilizing circRNAs and mRNAs biomarkers
A patient with advanced lung squamous cell carcinoma who failed to benefit from albumin bound paclitaxel plus pembrolizumab achieved partial response with second-line treatment of docetaxel plus pembrolizumab: a case report
Comparative clinical analysis of fever in tumor patients, normal patients, and those infected with new coronavirus pneumonia
S-nitrosylation-mediated coupling of G-protein alpha-2 with CXCR5 induces Hippo/YAP-dependent diabetes-accelerated atherosclerosis
Diagnostic Value of Imaging Combined With Tumor Markers in Early Detection of Lung Cancer
IFN-α, IFN-γ, IL-2 combined with TNF-α for predicting efficacy of PD-1 inhibitors combination therapy in patients with solid cancers.
Genomic alteration profiles of lung cancer and their relationship to clinical features and prognosis value using individualized genetic testing
Circular RNA as a potential biomarker for forensic age prediction using multiple machine learning models: A preliminary study
327 Study of anti-PD-1 antibody multimodal combination as first-line treatment on time window of advanced solid tumor
CircRNA: A novel biomarker for forensic age estimation?
Survival analysis of anticoagulant treatment of non-small cell lung cancer.
Risk factors of psychological distress and quality of life in lung cancer patients.
Immunoregulation of Bone Marrow-Derived Mesenchymal Stem Cells on the Chronic Cigarette Smoking-Induced Lung Inflammation in Rats